Literature DB >> 29268367

New histological classification and staging of thymic malignancies: ITMIG consensus statements and the 8th TNM staging system.

Jumpei Kashima1, Yusuke Okuma2.   

Abstract

Entities:  

Year:  2017        PMID： 29268367      PMCID： PMC5723884          DOI： 10.21037/jtd.2017.09.126

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  9 in total

1.  The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors.

Authors:  Frank C Detterbeck; Kelly Stratton; Dorothy Giroux; Hisao Asamura; John Crowley; Conrad Falkson; Pier Luigi Filosso; Aletta A Frazier; Giuseppe Giaccone; James Huang; Jhingook Kim; Kazuya Kondo; Marco Lucchi; Mirella Marino; Edith M Marom; Andrew G Nicholson; Meinoshin Okumura; Enrico Ruffini; Paul Van Schil
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

2.  Thymoma: a clinicopathologic study.

Authors:  P E BERNATZ; E G HARRISON; O T CLAGETT
Journal:  J Thorac Cardiovasc Surg       Date:  1961-10       Impact factor: 5.209

3.  Thymic hyperplasia and neoplasia: a review of current concepts.

Authors:  G D Levine; J Rosai
Journal:  Hum Pathol       Date:  1978-09       Impact factor: 3.466

4.  Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors.

Authors:  Alexandra Meurgey; Nicolas Girard; Claire Merveilleux du Vignaux; Jean-Michel Maury; François Tronc; Françoise Thivolet-Bejui; Lara Chalabreysse
Journal:  J Thorac Oncol       Date:  2017-07-08       Impact factor: 15.609

5.  A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma.

Authors:  K Koga; Y Matsuno; M Noguchi; K Mukai; H Asamura; T Goya; Y Shimosato
Journal:  Pathol Int       Date:  1994-05       Impact factor: 2.534

6.  Follow-up study of thymomas with special reference to their clinical stages.

Authors:  A Masaoka; Y Monden; K Nakahara; T Tanioka
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

7.  ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting.

Authors:  Alexander Marx; Philipp Ströbel; Sunil S Badve; Lara Chalabreysse; John K C Chan; Gang Chen; Laurence de Leval; Frank Detterbeck; Nicolas Girard; Jim Huang; Michael O Kurrer; Libero Lauriola; Mirella Marino; Yoshihiro Matsuno; Thierry Jo Molina; Kiyoshi Mukai; Andrew G Nicholson; Daisuke Nonaka; Ralf Rieker; Juan Rosai; Enrico Ruffini; William D Travis
Journal:  J Thorac Oncol       Date:  2014-05       Impact factor: 15.609

8.  Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus.

Authors:  M Marino; H K Müller-Hermelink
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

9.  Comparison of the Masaoka-Koga staging and the International Association for the Study of Lung Cancer/the International Thymic Malignancies Interest Group proposal for the TNM staging systems based on the Chinese Alliance for Research in Thymomas retrospective database.

Authors:  Guanghui Liang; Zhitao Gu; Yin Li; Jianhua Fu; Yi Shen; Yucheng Wei; Lijie Tan; Peng Zhang; Yongtao Han; Chun Chen; Renquan Zhang; Keneng Chen; Hezhong Chen; Yongyu Liu; Youbing Cui; Yun Wang; Liewen Pang; Zhentao Yu; Xinming Zhou; Yangchun Liu; Yuan Liu; Wentao Fang
Journal:  J Thorac Dis       Date:  2016-04       Impact factor: 2.895
  9 in total
  1 in total

Review 1.  Long Non-Coding RNAs in the Cell Fate Determination of Neoplastic Thymic Epithelial Cells.

Authors:  Alessia Iaiza; Claudia Tito; Federica Ganci; Andrea Sacconi; Enzo Gallo; Silvia Masciarelli; Giulia Fontemaggi; Alessandro Fatica; Enrico Melis; Vincenzo Petrozza; Federico Venuta; Mirella Marino; Giovanni Blandino; Francesco Fazi
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.